Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Hospitals & Diagnostics
    • Fortis Healthcare gets...

    Fortis Healthcare gets BSE,NSE nod for reclassification of promoters

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2019-06-05T12:39:14+05:30  |  Updated On 5 Jun 2019 12:39 PM IST
    Fortis Healthcare gets BSE,NSE nod for reclassification of promoters
    NEW DELHI: Fortis Healthcare on Monday said it has received approval from both bourses BSE and NSE for reclassification of its promoters including Singh brothers - Malvinder Mohan Singh and Shivinder Mohan Singh.

    The company has received approval from both the stock exchanges - BSE Ltd and NSE Ltd - for reclassification of the following promoters Malvinder Mohan Singh - Trust, Harpal Singh, Abhishek Singh, Malvinder Mohan Singh, Shivinder Mohan Singh, Fortis Healthcare Holdings Pvt Ltd, Malav Holdings Pvt Ltd and RHC Holding Pvt Ltd, Fortis Healthcare said in a filing to BSE. "The remaining promoter of the company is Northern TK Venture Pte. Ltd," it added.

    Read Also: Fortis Healthcare International to sell entire stake in MSCL

    Fortis in August 2018 had applied for reclassification of these promoters. Post reclassification, Northern TK Venture Pte Ltd remains the promoter of the firm with a 31.17 per cent stake in the healthcare firm.

    Shares of Fortis Healthcare closed at Rs 124.75 per scrip on BSE, down 0.40 per cent from its previous close.

    Read Also: Fortis Healthcare petitions SEBI seeking arrest of Singh brothers
    BSEFortisFortis Healthcarefortis healthcare promotersFortis promoters reclassificationFortis Singh brothersMalvinder Mohan SinghNew DelhiNorthern TK Venture Pte LtdNSEShares of Fortis HealthcareShivinder Mohan SinghSingh brothers
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok